Comparison of plasma tissue factor levels in unstable and stable angina pectoris

Am J Cardiol. 1998 Jan 1;81(1):22-6. doi: 10.1016/s0002-9149(97)00801-1.

Abstract

We have reported that the plasma levels of plasma fibrinopeptide A and plasminogen activator inhibitor activity increase in patients with unstable angina and acute myocardial infarction. Tissue factor (TF) is a low-molecular-weight glycoprotein that binds to and acts on essential cofactor VII, and the resulting complex activates factors IX and X, initiating the coagulation cascade. We measured plasma TF antigen levels in 21 patients with unstable angina (on admission and after treatment), 27 patients with stable exertional angina, and 27 control subjects. The 3 groups were matched for age, gender, and other clinical variables. The plasma TF antigen levels were higher in the unstable angina group than in the stable exertional angina and control groups (240 +/- 75 vs 184 +/- 46 and 177 +/- 37 pg/ml, p < 0.01). There were no significant differences in the plasma TF antigen levels between the stable exertional angina and the control groups. Furthermore, the plasma TF antigen levels were reexamined after treatment in the 21 patients with unstable angina. The mean level in these 21 patients decreased after 2 weeks of treatment (from 240 +/- 75 to 206 +/- 57 pg/ml, p < 0.01). This study suggests that the plasma TF antigen levels correlate with disease activity in patients with unstable angina. The increased plasma TF antigen levels in patients with unstable angina may reflect intravascular procoagulant activity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angina Pectoris / blood*
  • Angina Pectoris / etiology
  • Angina, Unstable / blood*
  • Angina, Unstable / drug therapy
  • Angina, Unstable / etiology
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Disease / complications
  • Coronary Disease / diagnostic imaging
  • Female
  • Humans
  • Male
  • Middle Aged
  • Physical Exertion
  • Severity of Illness Index
  • Thromboplastin / analysis*

Substances

  • Thromboplastin